These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10974195)

  • 21. Protein-Tyrosine Phosphatase-1B Mediates Sleep Fragmentation-Induced Insulin Resistance and Visceral Adipose Tissue Inflammation in Mice.
    Gozal D; Khalyfa A; Qiao Z; Akbarpour M; Maccari R; Ottanà R
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28651353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice.
    Gum RJ; Gaede LL; Koterski SL; Heindel M; Clampit JE; Zinker BA; Trevillyan JM; Ulrich RG; Jirousek MR; Rondinone CM
    Diabetes; 2003 Jan; 52(1):21-8. PubMed ID: 12502489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.
    Byon JC; Kusari AB; Kusari J
    Mol Cell Biochem; 1998 May; 182(1-2):101-8. PubMed ID: 9609119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes.
    Gonzalez-Rodriguez A; Clampit JE; Escribano O; Benito M; Rondinone CM; Valverde AM
    Endocrinology; 2007 Feb; 148(2):594-608. PubMed ID: 17068137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity.
    Zhang ZY; Lee SY
    Expert Opin Investig Drugs; 2003 Feb; 12(2):223-33. PubMed ID: 12556216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
    Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
    Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein tyrosine phosphatase 1B inhibitory activity of amentoflavone and its cellular effect on tyrosine phosphorylation of insulin receptors.
    Na M; Kim KA; Oh H; Kim BY; Oh WK; Ahn JS
    Biol Pharm Bull; 2007 Feb; 30(2):379-81. PubMed ID: 17268085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action.
    Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD
    Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.
    Ahmad F; Azevedo JL; Cortright R; Dohm GL; Goldstein BJ
    J Clin Invest; 1997 Jul; 100(2):449-58. PubMed ID: 9218523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
    Liu G; Trevillyan JM
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the C-terminal domain of protein tyrosine phosphatase-1B in phosphatase activity and substrate binding.
    Picha KM; Patel SS; Mandiyan S; Koehn J; Wennogle LP
    J Biol Chem; 2007 Feb; 282(5):2911-7. PubMed ID: 17135270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus.
    Ahmad F; Goldstein BJ
    Metabolism; 1995 Sep; 44(9):1175-84. PubMed ID: 7666792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro.
    Echwald SM; Bach H; Vestergaard H; Richelsen B; Kristensen K; Drivsholm T; Borch-Johnsen K; Hansen T; Pedersen O
    Diabetes; 2002 Jan; 51(1):1-6. PubMed ID: 11756316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of benzofuran scaffold-based potential PTP-1B inhibitors.
    Dixit M; Tripathi BK; Tamrakar AK; Srivastava AK; Kumar B; Goel A
    Bioorg Med Chem; 2007 Jan; 15(2):727-34. PubMed ID: 17095232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein tyrosine phosphatase 1B inhibitors for diabetes.
    Johnson TO; Ermolieff J; Jirousek MR
    Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
    Lorenzo M; Fernández-Veledo S; Vila-Bedmar R; Garcia-Guerra L; De Alvaro C; Nieto-Vazquez I
    J Anim Sci; 2008 Apr; 86(14 Suppl):E94-104. PubMed ID: 17940160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review.
    Verma M; Gupta SJ; Chaudhary A; Garg VK
    Bioorg Chem; 2017 Feb; 70():267-283. PubMed ID: 28043717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of a novel protein tyrosine phosphatase-1B inhibitor, KR61639: potential development as an antihyperglycemic agent.
    Cheon HG; Kim SM; Yang SD; Ha JD; Choi JK
    Eur J Pharmacol; 2004 Feb; 485(1-3):333-9. PubMed ID: 14757158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein tyrosine phosphatase 1B: a new target for the treatment of obesity and associated co-morbidities.
    Ukkola O; Santaniemi M
    J Intern Med; 2002 Jun; 251(6):467-75. PubMed ID: 12028501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances.
    Harley EA; Levens N
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1179-89. PubMed ID: 14649209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.